BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecule and chiral compounds.
| Product | Description | |
|---|---|---|
| D-myo-Inositol-1,3,6-triphosphate | D-myo-Inositol-1,3,6-triphosphate is a fundamental bioactive compound extensively utilized in the realm of intracellular calcium pathways, fostering the research of intricate cellular functions encompassing neurotransmitter emancipation, endocrine exudation and even the orchestration of musculature. Molecular formula: C6H15O15P3. Mole weight: 420.10. |  |
| D-myo-Inositol 1,4,5,6-tetraphosphate sodium salt | D-myo-Inositol 1,4,5,6-tetraphosphate sodium salt, known for its significance in the biomedical field, emerges as an indispensable compound governing intricate cellular mechanisms and intercellular signal transduction cascades. Synonyms: D-myo-Inositol 1,4,5,6-tetrakis(dihydrogen phosphate) tetrasodium salt; 1,4,5,6-IP4 sodium salt; Tetrasodium (1R,2S,3S,4R,5R,6S)-5,6-dihydroxy-1,2,3,4-cyclohexanetetrayl tetrakis[hydrogen (phosphate)]; 1,2,3,4,5,6-Cyclohexanehexol, 1,2,3,4-tetrakis(dihydrogen phosphate), sodium salt, (1R,2S,3S,4R,5R,6S)- (1:4). Grade: ≥98%. CAS No. 157542-47-7. Molecular formula: C6H12Na4O18P4. Mole weight: 588.00. | |
| D-Myo-inositol-1,4,5-triphosphate ammonium salt | D-Myo-inositol-1,4,5-triphosphate ammonium salt is a highly sought-after compound, manifesting as an instrumental entity in the intricate web of signal transduction pathways by functioning as a second messenger. Its paramount role lies in meticulously orchestrating calcium levels within cellular confines. Synonyms: D-myo-Inositol-1,4,5-tris(dihydrogen phosphate) Triammonium Salt; rac-(1R,2R,3S,4R,5R,6S)-3,5,6-Trihydroxycyclohexane-1,2,4-triyl tris(dihydrogen phosphate), Triammonia Salt; (1R,2R,3S,4R,5R,6S)-3,5,6-Trihydroxy-1,2,4-cyclohexanetriyl tris[dihydrogen (phosphate)] triammoniate; IP3(1,4,5). Grade: >99%. CAS No. 345958-55-6. Molecular formula: C6H24N3O15P3. Mole weight: 471.19. | |
| D-myo-Inositol 1,4,5-triphosphate potassium salt | D-myo-Inositol 1,4,5-triphosphate potassium salt is a paramount compound, finding extensive utility in the research of cellular signaling pathways. Serving as an inositol derivative, this product assumes the onerous responsibility of an efficacious second messenger for a myriad of intracellular phenomena. Unleashing its potential to mobilize calcium from intraorganic repositories, it assumes a critical function in the realm of neurotransmission investigation, cellular expansion and intricate proliferation exploration. Synonyms: D-myo-Inositol 1,4,5-trisphosphate hexapotassium salt; Ins(1,4,5)-P3 hexapotassium salt. CAS No. 103476-24-0. Molecular formula: C6H9K6O15P3. Mole weight: 648.64. | |
| D-myo-Inositol-1,4,5-triphosphate potassium salt | D-myo-Inositol-1,4,5-triphosphate (Ins(1,4,5)P3) is a second messenger produced in cells by phospholipase C (PLC) mediated hydrolysis of phosphatidyl inositol-4,5-biphosphate. It binds to one of several Ins(1,4,5)P3 receptors, each containing a calcium channel domain. Binding of Ins(1,4,5)P3 to the receptor results in opening of the calcium channels and an increase in intracellular calcium. Synonyms: D-MYO-INOSITOL 1,4,5-TRIPHOSPHATE TRIPOTASSIUM SALT; tripotassium; [(1R,2S,3R,4R,5S,6R)-2,3,5-trihydroxy-4,6-bis[[hydroxy(oxido)phosphoryl]oxy]cyclohexyl] hydrogen phosphate; D-Myo-inositol-1,2,5-tris(dihydrogen phosphate), tripotassium salt; PD020902; D-myo-Inositol 1,4,5-triphosphate tripotassium salt, >=95% (HPLC). Grade: ≥98%. CAS No. 141611-11-2. Molecular formula: C6H12O15P3·3K. Mole weight: 534.4. | |
| D-myo-Inositol 1,4,5-triphosphate sodium salt | D-myo-Inositol 1,4,5-triphosphate sodium salt is an imperative secondary messenger with pivotal involvement in numerous cell signaling pathways, this product exerts regulation over intracellular calcium levels. Its extensive research has revealed its significant contribution towards studying disorders associated with calcium imbalance, including neurodegenerative diseases, diabetes and cancer. CAS No. 27121-73-9. Molecular formula: C6H9Na6O15P3. Mole weight: 551.99. | |
| D-myo-Inositol-1,4,5-triphosphate sodium salt | D-myo-Inositol-1,4,5-triphosphate (Ins(1,4,5)P3) is a second messenger produced in cells by phospholipase C mediated hydrolysis of phosphatidyl inositol-4,5-biphosphate. Binding of Ins(1,4,5)P3 to the receptor results in opening of the calcium channels and an increase in intracellular calcium. Grade: ≥98%. CAS No. 141611-10-1. Molecular formula: C6H12Na3O15P3. Mole weight: 486.04. | |
| D-myo-Inositol 1,4,6-triphosphate sodium salt | D-myo-Inositol 1,4,6-triphosphate sodium salt is an extensively refined chemical compound employed in the biomedical sector assuming the role of an intracellular messenger, orchestrating intricate cellular processes, namely, cell growth and calcium signaling. It manifests pivotal significance in the research of maladies associated with the dysregulation of inositol phosphate pathways, encompassing select cancers, neurodegenerative disorders and metabolic irregularities. Synonyms: Ins(1,4,6)-P3 (sodium salt); 1,4,6-IP3 (sodium salt). CAS No. 157380-18-2. Molecular formula: C6H12O15P3.xNa. Mole weight: 417.07 (free acid basis). | |
| D-myo-Inositol-1,5,6-triphosphate sodium salt | D-myo-Inositol-1,5,6-triphosphate sodium salt is a fundamental compound prominently employed sector assuming an indispensable character within cellular signal transduction pathways, orchestrating sundry physiological processes. This prodigious entity operates as a secondary courier is adroitly overseeing calcium levels and intricately modulating multifarious cellular functionalities. Synonyms: 1,5,6-IP3 sodium salt; Ins(1,5,6)-P3 sodium salt; D-myo-Inositol, 1,2,6-tris(dihydrogen phosphate), sodium salt; D-Ins(1,2,6)P3 sodium salt; D-myo-1,2,6-Inositol trisphosphate sodium salt; D-myo-Inositol 1,2,6-triphosphate sodium salt; Atrinositol sodium salt; PP 56 sodium salt; α-Trinositol sodium salt. CAS No. 120965-76-6. Molecular formula: C6H15O15P3.xNa. Mole weight: 420.10 (free acid). | |
| D-myo-Inositol-2,3,5,6-tetraphosphate sodium salt | D-myo-inositol-2,3,5,6-tetraphosphate sodium salt is produced from Ins(1,2,3,5,6)P5 by a minor enzymatic phytate degradation pathway. And it is moderately effective in opening calcium channels than Ins(1,4,5)P3. Synonyms: 2,3,5,6-IP4 sodium salt; Ins(2,3,5,6)-P4 sodium salt; D-myo-inositol-2,3,5,6-tetrakis(dihydrogen phosphate), tetrasodium salt. Grade: ≥98%. Molecular formula: C6H12O18P4·4Na. Mole weight: 588. | |
| D-myo-Inositol-2,3,5-triphosphate ammonium salt | D-myo-Inositol-2,3,5-triphosphate ammonium salt is a member of the inositol phosphate (InsP) family of second messengers which play an important role in the transmission of cellular signals. Ins(2,3,5)P3 ammonium salt is 500-fold less potent than Ins(1,4,5)-P3 at initiating Ca2+ release when injected into Xenopus oocytes. Synonyms: Ins(2,3,5)P3 ammonium salt; 2,3,5-IP3 ammonium salt; D-myo-inositol-2,3,5-tris(dihydrogen phosphate), triammonium salt. Grade: ≥98%. Molecular formula: C6H12O15P3·3NH4. Mole weight: 522.3. | |
| D-myo-Inositol-2,3-O-cyclohexylidene | D-myo-Inositol-2,3-O-cyclohexylidene exhibits inhibitory efficacy in studyting a myriad of ailments such as diabetes, polycystic ovary syndrome (PCOS) and metabolic irregularities. Synonyms: hexahydrospiro[1,3-benzodioxole-2,1'-cyclohexane]-4,5,6,7-tetrol; Hexahydrospiro[benzo[d][1,3]dioxole-2,1'-cyclohexane]-4,5,6,7-tetraol; spiro[3a,4,5,6,7,7a-hexahydro-1,3-benzodioxole-2,1'-cyclohexane]-4,5,6,7-tetrol; spiro(2,4-dioxabicyclo[4.3.0]nonane-3,1'-cyclohexane)-6,7,8,9-tetrol. CAS No. 57029-87-5. Molecular formula: C12H20O6. Mole weight: 260.28. | |
| D-myo-Inositol-2,4,5-triphosphate sodium salt | D-myo-Inositol-2,4,5-triphosphate sodium salt is a second messenger produced in cells by phospholipase C (PLC)-mediated hydrolysis of phosphatidylinositol-4,5-biphosphate. Ins(2,4,5)P3 acts as a partial agonist at rat hepatic IP3 receptors, exhibiting 65% of the maximal Ca2+ response obtained with Ins(1,4,5)P3. Synonyms: Ins(2,4,5)P3 sodium salt; 2,4,5-IP3 sodium salt; D-myo-inositol-2,4,5-tris(hydrogen phosphate), trisodium salt. Grade: ≥98%. Molecular formula: C6H12O15P3·3Na. Mole weight: 486. | |
| D-myo-Inositol-2,5,6-triphosphate sodium salt | Ins(2,5,6)P3 is a less potent inducer of calcium release from permeabilized rat basophilic leukemia cells with an EC50 value of 110 μM compared to Ins(1,4,5)P3, which has an EC50 value of 0.17 μM. Synonyms: Ins(2,5,6)P3 sodium salt; 2,5,6-IP3 sodium salt; D-myo-inositol-2,5,6-tris(dihydrogen phosphate), trisodium salt. Grade: ≥98%. Molecular formula: C6H12O15P3·3Na. Mole weight: 486. | |
| D-myo-Inositol-3,4,5,6-tetraphosphate sodium salt | D-myo-Inositol-3,4,5,6-tetraphosphate sodium salt is one of several different inositol oligophosphate isomers implicated in signal transduction. It almost completely inhibits calcium-activated chloride channels at a concentration of 8-10 μM. And it was found to be inactive when analyzed for Ca2+-releasing potency in Xenopus oocytes. Synonyms: Ins(3,4,5,6)-P4; 3,4,5,6-IP4; D-myo-inositol-3,4,5,6-tetra(hydrogen phosphate), tetrasodium salt. Grade: ≥98%. Molecular formula: C6H12O18P4·4Na. Mole weight: 588. | |
| D-myo-Inositol-3,4,5-triphosphate | D-myo-Inositol-3,4,5-triphosphate is an indispensable molecule in the biomedical field, serving as a pivotal second messenger within intracellular signaling pathways, imposing control over calcium homeostasand intricate cellular mechanisms. Its significance lies in orchestrating critical processes, encompassing cellular proliferation, specialization and programmed cell death. The utilization of D-myo-Inositol-3,4,5-triphosphate prevails prominently in research endeavors and pharmaceutical advancements, with a primary focus on comprehending signal transduction, unraveling the complexities of neoplastic disorders and exploring promising therapeutic modalities. Synonyms: Ins(3,4,5)-P3; 3,4,5-IP4. CAS No. 112791-62-5. Molecular formula: C6H15O15P3. Mole weight: 420.10. | |
| D-myo-Inositol-3,4,5-triphosphate sodium salt | D-myo-Inositol-3,4,5-triphosphate (Ins(3,4,5)-P3) is a structural analog of Ins(1,4,5)-P3 and also a member of the inositol phosphate (InsP) cell signaling family of molecules. D-myo Ins(3,4,5)-P3 is 200-fold less potent than D-myo Ins(1,4,5)-P3 at initiating Ca++ release when injected into Xenopus oocytes. Ins(3,4,5)-P3 binds to Type 1, 2, and 3 subtypes of the rat recombinant IP3 receptor with Ki values of 3-11 μM. Synonyms: Ins(3,4,5)-P3; 3,4,5-IP4; D-myo-inositol-3,4,5-tris(hydrogen phosphate), trisodium salt. Grade: ≥98%. Molecular formula: C6H12O15P3·3Na. Mole weight: 486. | |
| D-myo-inositol 3-phosphate | D-myo-inositol 3-phosphate is an essential molecular compound extensively utilized in the research of diverse afflictions including Alzheimer's disease, depression and diabetes. Synonyms: Inositol 3-phosphate; 1D-myo-inositol 3-phosphate; L-myo-inositol 1-phosphate; 1L-myo-inositol 1-phosphate; D-myo-Inositol 3-monophosphate; 1D-myo-inositol 3-monophosphate; Inositol 3-monophosphate; myo-Inositol 3-phosphate; myo-Inositol 3-monophosphate; Myoinositol 3-phosphate; myo-Inositol-1-phosphate; LIP; Inositol-1-phosphate, myo-; 1L-myo-inositol 1-(dihydrogen phosphate); {[(2S,3R,5S,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphonic acid. CAS No. 2831-74-5. Molecular formula: C6H13O9P. Mole weight: 260.14. | |
| D-myo-Inositol-3-phosphate (sodium salt) | D-myo-Inositol-3-phosphate (sodium salt) is the second messenger of the inositol phosphate molecular family, which plays a key role in the transmission of cellular signals. It can be formed by dephosphorylation of polyphosphate inositols such as Ins(3,4)P2 by inositol polyphosphate 4-phosphatase. Synonyms: 3-IP1 (sodium salt); Ins(3)P1 (sodium salt); 1,2,3,4,5,6-Cyclohexanehexol, 1-(dihydrogen phosphate), sodium salt, (1α,2α,3α,4β,5α,6β)- (1:1); D-myo-inositol-3-hydrogen phosphate, monosodium salt. Grade: ≥95%. Molecular formula: C6H12NaO9P. Mole weight: 282.12. | |
| DNA31 | DNA31 is a potent inhibitor of RNA polymerase. Synonyms: Rifamycin VIII, 5'-(4-amino-1-piperidinyl)-1',4-didehydro-1-deoxy-1,4-dihydro-3'-hydroxy-1-oxo-. Grade: ≥95%. CAS No. 845626-57-5. Molecular formula: C48H58N4O13. Mole weight: 898.99. | |
| dNaM | dNaM is a synthetic biology tool used in genetic research for nucleotide modification. It allows for the creation of synthetic sequence-specific DNA-binding proteins for gene regulation and therapy. It has potential applications in treating genetic disorders and diseases like cancer through targeted gene editing. Grade: ≥ 97%. CAS No. 1117893-19-2. Molecular formula: C16H18O7. Mole weight: 274.31. | |
| DNA-PK Inhibitor IV | DNA-PK inhibitor IV is an inhibitor of DNA-dependent protein kinase (DNA-PK). It also inhibits the phosphatidylinositol 3-kinase (PI3K) isoforms p110β, p110δ, and p110γ but not p110α or class II PI3Ks, PI4Kβ, ATM, ATR, mTOR, CK2, or GRK2. Synonyms: 2-hydroxy-4-(4-morpholinyl)-benzaldehyde. Grade: ≥98%. CAS No. 70362-07-1. Molecular formula: C11H13NO3. Mole weight: 207.23. | |
| D-NMAPPD | D-NMAPPD is an inhibitor of ceramidase. It induces cell death in SW403 colon adenocarcinoma cells in a time- and concentration-dependent manner but doesn't have effect on viability of rat hepatocytes, Kupffer cells, or sinusoidal endothelial cells when used at a concentration of 100 mM. It also increases intracellular ceramide accumulation and cytochrome C release and induces apoptosis in SW403 cells. Synonyms: (1R,2R)-B13; CAY10466; N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]-tetradecanamide. Grade: ≥98%. CAS No. 35922-06-6. Molecular formula: C23H38N2O5. Mole weight: 422.6. | |
| D-Nonamannuronic Acid Nonasodium Salt | D-Nonamannuronic Acid Nonasodium Salt is a multifaceted biochemical compound, finding a multitude of applications, particularly in the production of potent antiviral drugs with exceptional efficacy against influenza A as well as B viruses. Synonyms: Nona-Mannuronic Acid Sodium Salt. Grade: ≥93% by GPC. Molecular formula: C54H65O55Na9. Mole weight: 1800.96. | |
| D-(-)-Norgestrel (Levonorgestrel) | Levonorgestrel is a synthetic progestogen used as an active ingredient in some hormonal contraceptives. Synonyms: SCH29851; SCH 29851; SCH-29851. Grade: >98%. CAS No. 797-63-7. Molecular formula: C21H28O2. Mole weight: 312.45. | |
| DNP CE Phosphoramidite | DNP CE Phosphoramidite is a paramount compound, serving as a multifaceted and adaptable solution for the orchestrated fabrication of personalized DNA oligonucleotides. Its pivotal role as a phosphoramidite building component in solid-phase synthesis fosters the precise integration of a DNP moiety at designated locales within the DNA sequence. Grade: >95% by HPLC. Molecular formula: C21H34N5O6P. Mole weight: 483.51. | |
| DNP-INT | DNP-INT is a quinone analog that inhibits electron transport in plants by competitively inhibiting plastoquinol oxidation by binding at the Qo site of cytochrome b6f (Kd = 1.4 nM). It inhibits electron flow from water to NADP or methylviologen by 50 and 100% when used at concentrations of 0.5 or 5 μM, respectively. Synonyms: 2-(2,4-dinitrophenoxy)-3-iodo-4-methyl-1-(1-methylethyl)-5-nitro-benzene; 2-Iodo-6-isopropyl-3-methyl-2',4,4'-trinitrodiphenyl ether; 4-(2,4-dinitrophenoxy)-3-iodo-2-methyl-1-nitro-5-propan-2-ylbenzene. Grade: ≥98%. CAS No. 69311-70-2. Molecular formula: C16H14IN3O7. Mole weight: 487.2. | |
| DNP-TEG CEP | DNP-TEG CEP is a prominent biomedical compound, used in research of mitochondrial dysfunction. In its remarkable capacity as a mitochondrial uncoupler, it efficaciously facilitates energy dissipation while curbing ATP synthesis. Notably, this revolutionary compound exhibits immense promise in studying the burden of metabolic disorders like obesity and diabetes. Synonyms: 1-Dimethoxytrityloxy-3-O-[N-(2,4-dinitrophenyl)-3-N-aminopropyl-(triethyleneglycol)]-glyceryl-2-O-(2-cyanoethyl)-(N,N-diisopropyl)-phosphoramidite; DNP-TEG Phosphoramidite; 1-[[Bis(4-methoxyphenyl)phenylmethoxy]methyl]-15-[(2,4-dinitrophenyl)amino]-3,6,9,12-tetraoxapentadec-1-yl 2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite; Phosphoramidous acid, N,N-bis(1-methylethyl)-, 1-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-15-[(2,4-dinitrophenyl)amino]-3,6,9,12-tetraoxapentadec-1-yl 2-cyanoethyl ester; DNP-TEG CED phosphoramidite. CAS No. 1027512-01-1. Molecular formula: C48H64N5O13P. Mole weight: 950.02. | |
| DNQX | DNQX is a selective non-NMDA receptor antagonist and could probably be useful in the treatment of Alzheimer's disease. Synonyms: 6,7-Dinitroquinoxaline-2,3-dione. Grade: ≥98% by HPLC. CAS No. 2379-57-9. Molecular formula: C8H4N4O6. Mole weight: 252.14. | |
| DNQX disodium salt | The sodium salt form of DNQX, which is a selective non-NMDA receptor antagonist and could probably be useful in the treatment of Alzheimer's disease. Synonyms: 6,7-Dinitroquinoxaline-2,3-dione disodium salt. Grade: ≥98% by HPLC. CAS No. 1312992-24-7. Molecular formula: C8H2N4O6Na2. Mole weight: 296.10. | |
| DNS-SGN | DNS-SGN is a powerful biopharmaceutical product used in the biomedical industry for targeted drug delivery. It is specifically designed to study various types of cancers, including breast cancer, lung cancer and ovarian cancer. DNS-SGN delivers potent cytotoxic drugs directly to cancer cells, enhancing research efficacy. Synonyms: DNS-SGN; D3690. Molecular formula: C100H155N9O66S. Mole weight: 2571.39. | |
| dNTP Bundle incl. dUTP | An equimolar(100 nm) mixture solution of ultrapure dATP, dCTP, dGTP and dUTP. Synonyms: 4 x 100 mM (dATP, dCTP, dGTP, dUTP); 2'-Deoxyadenosine-5'-triphosphate, Sodium salt; 2'-Deoxycytidine-5'-triphosphate, Sodium salt; 2'-Deoxyguanosine-5'-triphosphate, Sodium salt; 2'-Deoxyuridine-5'-triphosphate, Sodium salt. Grade: ≥ 99 % by HPLC. Molecular formula: dATP: C10H16N5O12P3(free acid); dCTP: C9H16N3O13P3(free acid); dGTP: C10H16N5O13P3(free acid); dUTP: C9H15N2O14P3(free acid). Mole weight: dATP: 491.18 (free acid); dCTP: 467.15 (free acid); dGTP: 507.186 (free acid); dUTP: 468.14 (free acid). | |
| dNTP Mix | A mixture solution of ultrapure dATP trisodium (1927-31-7), dCTP disodium (102783-51-7), dGTP trisodium (93919-41-6) and dTTP trisodium (18423-43-3). Used in PCR reaction. Synonyms: 4 x 100 mM (dATP, dCTP, dGTP, dTTP); 2'-Deoxyadenosine-5'-triphosphate, Sodium salt; 2'-Deoxycytidine-5'-triphosphate, Sodium salt; 2'-Deoxyguanosine-5'-triphosphate, Sodium salt; 2'-Deoxythymidine-5'-triphosphate, Sodium salt. Grade: ≥ 99 % by HPLC. Molecular formula: dATP 3Na: C10H13N5Na3O12P3; dCTP 2Na: C9H14N3Na2O13P3; dGTP 3Na: C10H13N5Na3O13P3; dTTP 3Na: C10H14N2Na3O14P3. Mole weight: dATP 3Na: 557.13; dCTP 2Na: 511.12; dGTP 3Na: 573.13; dTTP 3Na: 548.11. | |
| dNTP Mix / 10 mM | An equimolar (10 nm) mixture solution of ultrapure dATP, dCTP, dGTP and dTTP. Synonyms: Premix of 10 mM dATP, dCTP, dGTP and dTTP; 2'-Deoxyadenosine 5'-triphosphate, Sodium salt; 2'-Deoxycytidine 5'-triphosphate, Sodium salt; 2'-Deoxyguanosine 5'-triphosphate, Sodium salt; 2'-Deoxythymidine 5'-triphosphate, Sodium salt. Grade: ≥ 99 % by HPLC. Molecular formula: C10H13N5O12P3(Anion); C9H13N3O13P3(Anion); C10H13N5O13P3(Anion); C10H14N2O14P3(Anion). Mole weight: 488.16 (Anion); 464.13 (Anion); 504.16 (Anion); 479.14 (Anion). | |
| dNTP Mix / 25 mM | An equimolar (25 nm) mixture solution of ultrapure dATP, dCTP, dGTP and dTTP. Synonyms: Premix of 25 mM dATP, dCTP, dGTP and dTTP; 2'-Deoxyadenosine 5'-triphosphate, Sodium salt; 2'-Deoxycytidine 5'-triphosphate, Sodium salt; 2'-Deoxyguanosine 5'-triphosphate, Sodium salt; 2'-Deoxythymidine 5'-triphosphate, Sodium salt. Grade: ≥ 99 % by HPLC. Molecular formula: C10H13N5O12P3(Anion); C9H13N3O13P3(Anion); C10H13N5O13P3(Anion); C10H14N2O14P3(Anion). Mole weight: 488.16 (Anion); 464.13 (Anion); 504.16 (Anion); 479.14 (Anion). | |
| dNTP Mix GCamplifier / 10 mM | Modified dNTP mixture that could be used for amplification of GC-rich sequences. Synonyms: Modified dNTP Mix for amplification of GC-rich sequences. | |
| dNTP Mix incl. dUTP / 10 mM | An equimolar(10 nm) mixture solution of ultrapure dATP, dCTP, dGTP and dUTP. Synonyms: Premix of 10 mM dATP, dCTP, dGTP and 20 mM dUTP; 2'-Deoxyadenosine 5'-triphosphate, Sodium salt; 2'-Deoxycytidine 5'-triphosphate, Sodium salt; 2'-Deoxyguanosine 5'-triphosphate, Sodium salt; 2'-Deoxyuridine 5'-triphosphate, Sodium salt. Grade: ≥ 99 % by HPLC. Molecular formula: C10H13N5O12P3(Anion); C9H13N3O13P3(Anion); C10H13N5O13P3(Anion); C9H12N2O14P3(Anion). Mole weight: 488.16 (Anion); 464.13 (Anion); 504.16 (Anion); 465.12 (Anion). | |
| DNV-II impurity 1 | N-[(1R,2S)-2-Hydroxy-3-[(2-methylpropyl)[(4-nitrophenyl)sulfonyl]amino]-1-(phenylmethyl)propyl]carbamic acid 1,1-dimethylethyl ester is an impurity of Darunavir, a human immunodeficiency virus (HIV) protease inhibitor that is used to treat patients with drug-resistant HIV. Synonyms: N-[(1R,2S)-2-Hydroxy-3-[(2-methylpropyl)[(4-nitrophenyl)sulfonyl]amino]-1-(phenylmethyl)propyl]carbamic Acid 1,1-Dimethylethyl Ester. Grade: > 95%. CAS No. 1005324-46-8. Molecular formula: C25H35N3O7S. Mole weight: 521.63. | |
| DNV-II impurity 2 | N-[(1S,2S)-2-Hydroxy-3-[(2-methylpropyl)[(4-nitrophenyl)sulfonyl]amino]-1-(phenylmethyl)propyl]carbamic acid 1,1-dimethylethyl ester is an impurity of Darunavir, a human immunodeficiency virus (HIV) protease inhibitor that is used to treat patients with drug-resistant HIV. Synonyms: N-[(1S,2S)-2-Hydroxy-3-[(2-methylpropyl)[(4-nitrophenyl)sulfonyl]amino]-1-(phenylmethyl)propyl]carbamic Acid 1,1-Dimethylethyl Ester. Grade: > 95%. CAS No. 1133153-38-4. Molecular formula: C25H35N3O7S. Mole weight: 521.63. | |
| DO264 | DO264 is a potent, selective, and in vivo active ABHD12 inhibitor. DO264 inhibits ABHD12 and increases lyso-PS content in human monocytic cells. Synonyms: DO-264; DO 264; 1-(1-(3-Chloro-4-(2-chloro-4-(trifluoromethoxy)phenoxy)pyridin-2-yl)piperidin-4-yl)-3-(pyridin-3-yl)thiourea. Grade: 99%. CAS No. 2301866-59-9. Molecular formula: C23H20Cl2F3N5O2S. Mole weight: 558.40. | |
| DO2A | DO2A is an impurity of Gadoteridol. Gadoterido is a gadolinium-based MRI contrast agent. It is sold under the brand name ProHance. Grade: > 95%. Molecular formula: C12H24N4O4. Mole weight: 288.34. | |
| Dobutamine | Dobutamine is a catecholamine used to treat heart failure by inhibiting β1 receptors in the sympathetic nervous system. Uses: Β1- and β2-adrenoceptor agonist with some action at the α1-adrenoceptor. Synonyms: Dobutamina; Dobutrex; (RS)-4-(2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)benzene-1,2-diol; (+-)-4-(2-((3-(p-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol. Grade: ≥98%. CAS No. 34368-04-2. Molecular formula: C18H23NO3. Mole weight: 301.38. | |
| Dobutamine hydrochloride | Dobutamine is a sympathomimetic drug used in the treatment of heart failure and cardiogenic shock. Its primary mechanism is direct stimulation of β1 receptors of the sympathetic nervous system. Synonyms: 4-(2-((4-(4-hydroxyphenyl)butan-2-yl)amino)ethyl)benzene-1,2-diol hydrochloride; LY 81929; LY-81929; LY81929; Dobutamine; Dobutamina. Grade: >98%. CAS No. 49745-95-1. Molecular formula: C18H24ClNO3. Mole weight: 337.84. | |
| Dobutamine Impurity C HCl | A trimethoxy precursor and impurity of Dobutamine. Synonyms: N-[2-(3,4-Dimethoxyphenyl)ethyl]-4-methoxy-α-methylbenzenepropanamine Hydrochloride; Trimethoxydobutamine Hydrochloride. Grade: > 95%. CAS No. 51062-14-7. Molecular formula: C21H29NO3·HCl. Mole weight: 379.92. | |
| Docetaxel 2',7,10-Tris(triethylsilyl) Ether | Docetaxel 2',7,10-Tris(triethylsilyl) Ether is a derivative of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: 2',7,10-Tris(triethylsilyl)docetaxel; [2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-β-[[(1,1-Dimethylethoxy)carbonyl]amino]-α-[(triethylsilyl)oxy]-benzenepropanoic Acid 12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4,6-bis[(triethylsilyl)oxy]-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester; (2α,5β,7β,10β,13α)-4-Acetoxy-1-hydroxy-13-({(2R,3S)-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenyl-2-[(triethylsilyl)oxy]propanoyl}oxy)-9-oxo-7,10-bis[(triethylsilyl)oxy]-5,20-epoxytax-11-en-2-yl benzoate. Grade: ≥95%. CAS No. 149107-86-8. Molecular formula: C61H95NO14Si3. Mole weight: 1150.66. | |
| Docetaxel Crotonaldehyde Analog | Docetaxel Crotonaldehyde Analog is an impurity of Docetaxel. Grade: > 95%. Molecular formula: C43H51NO14. Mole weight: 805.86. | |
| Docetaxel EP Impurity A | Docetaxel EP Impurity A is an impurity of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: 2-O-desbenzoyl-2-O-tiglyldocetaxel; 5β,20-epoxy-1,7β,10β-trihydroxy-9-oxotax-11-ene-2α,4,13α-triyl 4-acetate 13-[(2R,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-phenylpropanoate] 2-[(2E)-2-methylbut-2-enoate]. CAS No. 1887057-05-7. Molecular formula: C41H55NO14. Mole weight: 785.87. | |
| Docetaxel EP Impurity B | A novel taxoid having remarkable anti-tumor properties. Docetaxel intermediate. This product is unstable in solution, epimerize. Synonyms: 6-Oxo Docetaxel (USP); 10-Oxo Docetaxel; 10-Deoxy-10-Oxo Docetaxel; 5β,20-Epoxy-1,7β-dihydroxy-9,10-dioxotax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-[(2R,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-phenylpropanoate] (as per EP); (2aR,4S,4aS,9S,11S,12S,12aR,12bS)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-Dodecahydro-4,9,11,12,12b-pentahydroxy-4a,8,13,13-tetramethyl-7,11-methano-5H-cyclodeca[3,4]benz[1,2-b]oxet-5,6-dione 12b-acetate, 12-benzoate, 9-ester. Grade: >98%. CAS No. 167074-97-7. Molecular formula: C43H51NO14. Mole weight: 805.86. | |
| Docetaxel EP Impurity C | Docetaxel EP Impurity C is an impurity of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: 4-epi-Docetaxel (USP); 4-Epidocetaxel; 7-Epidocetaxel; 7-Epitaxotere; 5β,20-epoxy-1,7α,10β-trihydroxy-9-oxotax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-[(2R,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-phenylpropanoate]. Grade: >98%. CAS No. 153381-68-1. Molecular formula: C43H53NO14. Mole weight: 807.88. | |
| Docetaxel EP Impurity D | Docetaxel EP Impurity D is an impurity of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: 4-Epi-6-Oxo Docetaxel (USP); 10-Deoxy-10-Oxo-7-epi-Docetaxel; 4-epi-6-Oxodocetaxel; 5β,20-Epoxy-1,7α-dihydroxy-9,10-dioxotax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-[(2R,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-phenylpropanoate]. Grade: >98%. CAS No. 162784-72-7. Molecular formula: C43H51NO14. Mole weight: 805.86. | |
| Docetaxel EP Impurity G | Docetaxel EP Impurity G is an impurity of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: 10-Acetyl Docetaxel (EP); Docetaxal; N-Debenzoyl-N-(tert-butoxycarbonyl)taxol; 5β,20-Epoxy-1,7β-dihydroxy-9-oxotax-11-ene-2α,4,10β,13α-tetrayl 4,10-diacetate 2-benzoate 13-[(2R,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-henylpropanoate]. Grade: > 95%. CAS No. 125354-16-7. Molecular formula: C45H55NO15. Mole weight: 849.94. | |
| Docetaxel Hydrate | Docetaxel Hydrate, a semisynthetic derivative of Paclitaxel, is used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Uses: A semisynthetic derivative of paclitaxel. an antimitotic agent that promotes the assembly of micro-tubules and inhibits their de-polymerization to free tubulin. an antineoplastic. Synonyms: (αR,βS)-β-[[(1,1-Dimethylethoxy)carbonyl]amino]-α-hydroxybenzenepropanoic Acid(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester Hydrate; N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Hydrate; RP 56976 Hydrate; Taxotere Hydrate. CAS No. 700367-34-6. Molecular formula: C43H53NO14.xH2O. Mole weight: 807.88 (anhydrous). | |
| Docetaxel Hydroxy tert-Butylcarbamate | Docetaxel Hydroxy tert-Butylcarbamate is a metabolite of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: Docetaxel Metabolite M2; RPR-104952; Benzenepropanoic acid, α-hydroxy-β-[[(2-hydroxy-1,1-dimethylethoxy)carbonyl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-; (2α,5β,7β,10β,13α)-4-Acetoxy-1,7,10-trihydroxy-13-{[(2R,3S)-2-hydroxy-3-({[(1-hydroxy-2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate. Grade: ≥95%. CAS No. 154044-57-2. Molecular formula: C43H53NO15. Mole weight: 823.88. | |
| Docetaxel Impurity 1 | A metabolite of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: (αR,βS)-β-[[(1,1-Dimethylethoxy)carbonyl]amino]-α-hydroxybenzenepropanoic Acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-6-[[(2,2-dichloroethoxy)carbonyl]oxy]-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,1. Grade: > 95%. CAS No. 158810-73-2. Molecular formula: C46H55Cl2NO16. Mole weight: 948.83. | |
| Docetaxel Impurity 19 | Docetaxel Impurity 19 is an impurity of Docetaxel, a chemotherapy drug used to treat a variety of cancers. CAS No. 92950-45-3. Molecular formula: C29H34O10. Mole weight: 542.58. | |
| Docetaxel Impurity 2 | A metabolite of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: Benzenepropanoic acid, -[[(1,1-dimethylethoxy)carbonyl]amino]--hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-4-[[(2,2-dichloroethoxy)carbonyl]oxy]-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-6,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (R,S)-. Grade: > 95%. CAS No. 158810-72-1. Molecular formula: C46H55Cl2NO16. Mole weight: 948.83. | |
| Docetaxel Impurity 3 | A new analog of 10-Deacetylbaccatin III. Synonyms: 13-epi-10-Deacetyl Baccatin III; [2aR-(2aα,4β,4aβ,6β,9β,11α,12α,12aα,12bα)]-12b-(Acetyloxy)-12-(benzoyloxy)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-dodecahydro-4,6,9,11-tetrahydroxy-4a,8,13,13-tetramethyl-7,11-methano-5H-cyclodeca[3,4]benz[1,2-b]oxet-5-one; 13-e. Grade: > 95%. CAS No. 172018-16-5. Molecular formula: C29H36O10. Mole weight: 544.59. | |
| Docetaxel Impurity 4 | Docetaxel intermediate. Synonyms: (4S,5S)-2,2-Dimethyl-4-phenyl-,5-oxazolidinedicarboxylic Acid 3-(1,1-Dimethylethyl) Ester. Grade: > 95%. CAS No. 153744-63-9. Molecular formula: C17H23NO5. Mole weight: 321.37. | |
| Docetaxel Impurity 44 | Docetaxel Impurity 44 is an impurity of Docetaxel, a chemotherapy drug used to treat a variety of cancers. CAS No. 1095547-96-8. Molecular formula: C46H54Cl3NO16. Mole weight: 983.28. | |
| Docetaxel Impurity 45 | Docetaxel Impurity 45 is an impurity of Docetaxel, a chemotherapy drug used to treat a variety of cancers. CAS No. 1095547-98-0. Molecular formula: C46H54Cl3NO16. Mole weight: 983.28. | |
| Docetaxel Impurity 5 | Docetaxel Impurity 5 is an impurity of Docetaxel, a chemotherapy drug used to treat a variety of cancers. CAS No. 1021489-55-3. Molecular formula: C46H55NO16. Mole weight: 877.94. | |
| Docetaxel Metabolite M4 | Docetaxel Metabolite M4 is a metabolite of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: RPR 104943; (2α,5β,7β,10β,13α)-4-Acetoxy-13-{[(2R,3S)-3-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2-hydroxy-3-phenylpropanoyl]oxy}-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate; 3-Oxazolidinepropanoic acid, α-hydroxy-5,5-dimethyl-2,4-dioxo-β-phenyl-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-. Grade: 95%. CAS No. 157067-34-0. Molecular formula: C43H49NO15. Mole weight: 819.852. | |
| Docetaxel Trihydrate | Docetaxel is a cytotoxic agent, which is related to its ability to promote the formation of microtubule bundles and induce sustained mitotic arrest, followed by apoptosis of mitotically arrested cells or permanent mitotic block. Synonyms: 7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete Benzenepropanoic Acid Deriv.; [2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-ylester-β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-benzenepropanoic Acid Trihydrate; (αR,βS)-(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-ylester-β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-benzenepropanoic Acid Trihydrate; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel trihydrate; 4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate--water (1/3); Docetaxel (USP) RP56976 (NSC 628503) Trihydrate; RP 56976 (NSC-628503) Trihydrate; RP-56976 (NSC628503) Trihydrate. Grade: 98%. CAS No. 148408-66-6. | |
| Docosahexaenoyl Ethanolamide | Docosahexaenoyl ethanolamide (DHEA) is the ethanolamine amide of DHA that has been detected in both brain and retina. DHEA binds to the rat brain CB1 receptor with a Ki of 324 nM, which is approximately 10-fold higher than the Ki for AEA. It also inhibits shaker-related voltage-gated potassium channels in brain slightly better than AEA, with an IC50 of 1.5 μM. Synonyms: C22:6 anandamide; DHEA; Synaptamide; N-(2-hydroxyethyl)-4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenamide. Grade: >99%. CAS No. 162758-94-3. Molecular formula: C24H37NO2. Mole weight: 371.57. | |
| Docosatetraenoyl Ethanolamide | Docosatetraenoyl ethanolamide (DEA) is a potent endocannabinoid and anandamide analog containing docosatetraenoic acid in place of the arachidonate moiety of AEA. DEA acts on CB1 receptors in microglia and binds to rat synaptosomal membranes (Ki = 34.4 nM). Synonyms: DEA; N-(2-hydroxyethyl)-7Z,10Z,13Z,16Z-docosatetraenamide; 7,10,13,16-Docosatetraenylethanolamide; Adrenoyl-EA. Grade: ≥98%. CAS No. 150314-35-5. Molecular formula: C24H41NO2. Mole weight: 375.6. | |
| Docosatrienoic Acid | Docosatrienoic acid is a rare ω-3 fatty acid, not readily detected in normal phospholipid PUFA pools. Docosatrienoic acid inhibits LTB4 binding to pig neutrophil membranes (Ki= 5 μM). Synonyms: docosa-13,16,19-trienoic acid. CAS No. 28845-86-5. Molecular formula: C22H38O2. Mole weight: 334.54. | |
| D-Octamannuronic Acid Octasodium Salt | D-Octamannuronic Acid Octasodium Salt is an extraordinary biomedical compound that exhibits remarkable potential in research of a myriad of ailments, including cardiovascular disorders and inflammation.This prodigious compound demonstrates promising efficacy against bacterial infections through its profound disruption of biofilm formation. Synonyms: Octa-Mannuronic Acid Sodium Salt. Grade: ≥94% by GPC. Molecular formula: C48H58O49Na8. Mole weight: 1602.86. | |
| Docusate Sodium Related Compound B | Docusate sodium Related Compound B. Synonyms: Disodium mono(2-ethylhexyl) sulfosuccinate. Grade: > 95%. CAS No. 86878-53-7. Molecular formula: C12H20O7S. Mole weight: 354.33. | |
| Docusate sodium salt | Docusate Sodium is a laxative used to treat constipation by absorbing into the bloodstream and excreted via the gallbladder after undergoing extensive metabolism. Uses: A laxative used to treat constipation. Synonyms: Sodium 1,4-bis(2-ethylhexyl) sulfosuccinate; Bis(2-ethylhexyl) sodium sulfosuccinate; dioctyl sodium sulfosuccinate; DSS; sodium dioctyl sulfosuccinate; sulfo-butanedioic acid 1,4-bis(2-ethylhexyl) ester, sodium salt; sulfosuccinic acid 1,4-bis(2-ethylhexyl) ester sodium salt. Grade: ≥95%. CAS No. 577-11-7. Molecular formula: C20H37NaO7S. Mole weight: 444.56. | |
| Dodecamethylpentasiloxane | Dodecamethylpentasiloxane exhibits insecticidal activity against bed bug. Uses: A non-cyclic polydimethyl siloxane. study shows that it can be transformed by a specific microflora and in the natural environment degraded by mechanisms similar to other organic compounds. Synonyms: 1,1,1,3,3,5,5,7,7,9,9,9-Dodecamethylpentasiloxane; dodecamethyl pentasiloxane. CAS No. 141-63-9. Molecular formula: C12H36O4Si5. Mole weight: 384.84. | |
Our database is helping our users find suppliers everyday.
